John Bacon

John BaconJohn Bacon is a founder and CEO of iP2Biz LLC, an Innovation Capitalist that translates corporate demand for breakthrough technologies into commercial action. Searching at major research universities, iP2Biz vets new technologies and co-invests with clients to do translational research before conveying a license to the client for further development into a commercial product.  The company’s focus is on materials, sustainable energy and environmental technologies.  Mr. Bacon has spent his entire career involved with early stage technology, creating early markets for emerging technologies. He worked for 17 years with Scientific-Atlanta, Inc. (now Cisco), in a variety of roles culminating as Group Executive of Satellite Communications.  He is a trustee of the Georgia Tech Foundation and Chair-elect of Georgia Tech Research Institute.  Mr. Bacon is a faculty member for the NSF I-Corps program.

Russell Donda

Russ Donda

Currently serving as the Entrepreneur-in-Residence for medical device and biosensor technologies at the Great Lakes Innovation & Development Enterprise, BioEnterprise and Jumpstart, as well as LCCC’s Director for the Office of Community Technology Transfer, Russell Donda has more than 25 years of management experience at both executive and entrepreneurial levels. Among other projects, Mr. Donda was the founding CEO and chairman of the board for ViewRay Incorporated, (www.viewray.com), a company developing a novel form of radiation therapy; it was subsequently venture funded by Aisling Capital, Fidelity Biosciences, Kearny Venture Partners, OrbiMed Advisors and Siemens Venture Capital (SVC) GmbH. Mr. Donda was a founding member of, and co-chair of investment review for, the Emergent Growth Fund, LLC (www.emergentgrowth.com), an angel investment fund focused on technology businesses; additionally, he was a founding manager of, and spearheaded business development for, the allograft implant company, Regeneration Technologies (www.rtix.com), a privately held, for-profit spinout of The University of Florida Orthopedic Tissue Bank which went public after three years in operation.